Stuart M. Allan

Interleukin-1 and neuronal injury.

The neurovascular unit and the key role of astrocytes in the regulation of cerebral blood flow.

A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke.

Interleukin-1 in Stroke: From Bench to Bedside.

Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia.

Translational models for vascular cognitive impairment: a review including larger species.

A quantitative brain map of experimental cerebral malaria pathology.

Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro.

Isolation and Cultivation of Primary Brain Endothelial Cells from Adult Mice.

The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments).

Boron-Based Inhibitors of the NLRP3 Inflammasome.

Assessing Inflammation in Acute Intracerebral Hemorrhage with PK11195 PET and Dynamic Contrast-Enhanced MRI.

Acute high-fat feeding leads to disruptions in glucose homeostasis and worsens stroke outcome.

Microglial Priming as Trained Immunity in the Brain.

Neutrophil infiltration to the brain is platelet-dependent, and is reversed by blockade of platelet GPIbα.

Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.

SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial.

Development of a characterised tool kit for the interrogation of NLRP3 inflammasome-dependent responses.

Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology.

The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke.

Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria.

Generation of Human Mesenchymal Stem Cell 3D Spheroids Using Low-binding Plates.

Pentraxin 3 promotes long-term cerebral blood flow recovery, angiogenesis, and neuronal survival after stroke.

Small, Thin Graphene Oxide Is Anti-inflammatory Activating Nuclear Factor Erythroid 2-Related Factor 2 via Metabolic Reprogramming.

Interleukin-1 mediates ischaemic brain injury via distinct actions on endothelial cells and cholinergic neurons.

Using zebrafish larval models to study brain injury, locomotor and neuroinflammatory outcomes following intracerebral haemorrhage.

Stroke: The past, present and future.

Vascular dysfunction-The disregarded partner of Alzheimer's disease.

Ligature-induced periodontitis induces systemic inflammation but does not alter acute outcome after stroke in mice.

Extent of Ischemic Brain Injury After Thrombotic Stroke Is Independent of the NLRP3 (NACHT, LRR and PYD Domains-Containing Protein 3) Inflammasome.